Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Cannabinoid-like Effects of Five Novel Carboxamide Synthetic Cannabinoids.

Gatch MB, Forster MJ.

Neurotoxicology. 2018 Nov 12. pii: S0161-813X(18)30378-4. doi: 10.1016/j.neuro.2018.11.004. [Epub ahead of print]

PMID:
30439379
2.

Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis.

Dolan SB, Shetty RA, Forster MJ, Gatch MB.

J Psychopharmacol. 2018 Jul;32(7):802-810. doi: 10.1177/0269881118780613. Epub 2018 Jun 18.

PMID:
29909719
3.

Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor.

Baladi MG, Forster MJ, Gatch MB, Mailman RB, Hyman DL, Carter LP, Janowsky A.

J Pharmacol Exp Ther. 2018 Aug;366(2):367-376. doi: 10.1124/jpet.118.248120. Epub 2018 Jun 11.

PMID:
29891587
4.

"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.

Dolan SB, Chen Z, Huang R, Gatch MB.

Neuropharmacology. 2018 May 1;133:171-180. doi: 10.1016/j.neuropharm.2018.01.020. Epub 2018 Jan 31.

PMID:
29378213
5.

Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats.

Gatch MB, Forster MJ.

Psychopharmacology (Berl). 2018 Mar;235(3):673-680. doi: 10.1007/s00213-017-4783-6. Epub 2017 Nov 14.

PMID:
29138877
6.

Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Dolan SB, Forster MJ, Gatch MB.

Drug Alcohol Depend. 2017 Nov 1;180:39-45. doi: 10.1016/j.drugalcdep.2017.07.041. Epub 2017 Aug 24.

PMID:
28865391
7.

Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Gatch MB, Dolan SB, Forster MJ.

Behav Pharmacol. 2017 Aug;28(5):375-385. doi: 10.1097/FBP.0000000000000309.

8.

Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.

Gatch MB, Dolan SB, Forster MJ.

Psychopharmacology (Berl). 2017 Apr;234(8):1237-1245. doi: 10.1007/s00213-017-4562-4. Epub 2017 Feb 16.

9.

Neuropharmacology of N,N-dimethyltryptamine.

Carbonaro TM, Gatch MB.

Brain Res Bull. 2016 Sep;126(Pt 1):74-88. doi: 10.1016/j.brainresbull.2016.04.016. Epub 2016 Apr 25. Review.

10.

Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Gatch MB, Dolan SB, Forster MJ.

Behav Pharmacol. 2016 Sep;27(6):497-505. doi: 10.1097/FBP.0000000000000237.

11.

Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.

Gatch MB, Forster MJ.

Psychopharmacology (Berl). 2016 May;233(10):1901-10. doi: 10.1007/s00213-016-4237-6. Epub 2016 Feb 15.

12.

Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.

Gatch MB, Forster MJ.

Behav Pharmacol. 2015 Aug;26(5):460-8. doi: 10.1097/FBP.0000000000000150.

13.

Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives.

Gatch MB, Dolan SB, Forster MJ.

J Pharmacol Exp Ther. 2015 Aug;354(2):103-10. doi: 10.1124/jpet.115.223586. Epub 2015 May 21.

14.

Abuse liability of the dietary supplement dimethylamylamine.

Dolan SB, Gatch MB.

Drug Alcohol Depend. 2015 Jan 1;146:97-102. doi: 10.1016/j.drugalcdep.2014.11.006. Epub 2014 Nov 25.

15.

Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.

Gatch MB, Forster MJ.

Behav Pharmacol. 2014 Dec;25(8):750-7. doi: 10.1097/FBP.0000000000000093.

16.

Discriminative and locomotor effects of five synthetic cathinones in rats and mice.

Gatch MB, Rutledge MA, Forster MJ.

Psychopharmacology (Berl). 2015 Apr;232(7):1197-205. doi: 10.1007/s00213-014-3755-3. Epub 2014 Oct 5.

17.

The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.

Carbonaro TM, Eshleman AJ, Forster MJ, Cheng K, Rice KC, Gatch MB.

Psychopharmacology (Berl). 2015 Jan;232(1):275-84. doi: 10.1007/s00213-014-3658-3. Epub 2014 Jul 3.

18.

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Eshleman AJ, Forster MJ, Wolfrum KM, Johnson RA, Janowsky A, Gatch MB.

Psychopharmacology (Berl). 2014 Mar;231(5):875-88. doi: 10.1007/s00213-013-3303-6. Epub 2013 Oct 19.

19.

Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.

Gatch MB, Taylor CM, Forster MJ.

Behav Pharmacol. 2013 Sep;24(5-6):437-47. doi: 10.1097/FBP.0b013e328364166d.

20.

The HIV antiretroviral drug efavirenz has LSD-like properties.

Gatch MB, Kozlenkov A, Huang RQ, Yang W, Nguyen JD, González-Maeso J, Rice KC, France CP, Dillon GH, Forster MJ, Schetz JA.

Neuropsychopharmacology. 2013 Nov;38(12):2373-84. doi: 10.1038/npp.2013.135. Epub 2013 May 24.

21.

Discriminative stimulus effects of N,N-diisopropyltryptamine.

Carbonaro TM, Forster MJ, Gatch MB.

Psychopharmacology (Berl). 2013 Mar;226(2):241-6. doi: 10.1007/s00213-012-2891-x. Epub 2012 Oct 16.

22.

Carisoprodol tolerance and precipitated withdrawal.

Gatch MB, Nguyen JD, Carbonaro T, Forster MJ.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):29-34. doi: 10.1016/j.drugalcdep.2011.10.010. Epub 2011 Nov 4.

23.

Behavioral and toxicological effects of propofol.

Gatch MB, Forster MJ.

Behav Pharmacol. 2011 Oct;22(7):718-22. doi: 10.1097/FBP.0b013e32834aff84.

24.

Abuse liability profile of three substituted tryptamines.

Gatch MB, Forster MJ, Janowsky A, Eshleman AJ.

J Pharmacol Exp Ther. 2011 Jul;338(1):280-9. doi: 10.1124/jpet.111.179705. Epub 2011 Apr 7.

25.

Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.

Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ.

J Med Chem. 2009 Nov 12;52(21):6768-81. doi: 10.1021/jm901189z.

PMID:
19821577
26.

The effects of chronic cocaine exposure on impulsivity in rats.

Dandy KL, Gatch MB.

Behav Pharmacol. 2009 Sep;20(5-6):400-5. doi: 10.1097/FBP.0b013e328330ad89.

27.

Ethanol withdrawal and hyperalgesia.

Gatch MB.

Curr Drug Abuse Rev. 2009 Jan;2(1):41-50. Review.

PMID:
19630736
28.

Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.

Gatch MB, Rutledge MA, Carbonaro T, Forster MJ.

Psychopharmacology (Berl). 2009 Jul;204(4):715-24. doi: 10.1007/s00213-009-1501-z. Epub 2009 Mar 14.

29.

Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies.

Gonzalez LA, Gatch MB, Taylor CM, Bell-Horner CL, Forster MJ, Dillon GH.

J Pharmacol Exp Ther. 2009 May;329(2):827-37. doi: 10.1124/jpet.109.151142. Epub 2009 Feb 24.

30.

Abuse Potential of Soma: the GABA(A) Receptor as a Target.

Gonzalez LA, Gatch MB, Forster MJ, Dillon GH.

Mol Cell Pharmacol. 2009 Jan 1;1(4):180-186.

31.

Nicotine and methamphetamine share discriminative stimulus effects.

Gatch MB, Flores E, Forster MJ.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):63-71. Epub 2007 Oct 24.

32.

Tolerance to the antinociceptive effects of ethanol during ethanol withdrawal.

Gatch MB.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):946-52. Epub 2006 Mar 30.

PMID:
16574295
33.

Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Gatch MB, Taylor CM, Flores E, Selvig M, Forster MJ.

Behav Pharmacol. 2006 Mar;17(2):151-9.

34.

Ethanol substitutes for the discriminative stimulus effects of m-chlorophenylpiperazine.

Gatch MB.

Brain Res. 2005 Nov 16;1062(1-2):161-5. Epub 2005 Oct 26.

PMID:
16256082
35.

GABAergic modulation of the discriminative stimulus effects of methamphetamine.

Gatch MB, Selvig M, Forster MJ.

Behav Pharmacol. 2005 Jul;16(4):261-6.

36.

Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanisms.

Jung ME, Gatch MB, Simpkins JW.

Exp Biol Med (Maywood). 2005 Jan;230(1):8-22. Review.

PMID:
15618121
37.

Effects of ethanol on cocaine discrimination in rats.

Gatch MB, Youngblood BD, Forster MJ.

Pharmacol Biochem Behav. 2003 Jul;75(4):837-44.

38.
40.

Effects of GABA(A) compounds on mCPP drug discrimination in rats.

Gatch MB, Jung ME, Wallis CJ, Lal H.

Life Sci. 2002 Oct 18;71(22):2657-65.

PMID:
12354584
41.

The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments.

Jung ME, Lal H, Gatch MB.

Neurosci Biobehav Rev. 2002 Jun;26(4):429-39. Review.

PMID:
12204190
42.

Nitrendipine blocks the nociceptive effects of chronically administered ethanol.

Gatch MB.

Alcohol Clin Exp Res. 2002 Aug;26(8):1181-7.

PMID:
12198392
43.

Theophylline blocks ethanol withdrawal-induced hyperalgesia.

Gatch MB, Selvig M.

Alcohol Alcohol. 2002 Jul-Aug;37(4):313-7.

PMID:
12107030
44.

Effects of calcium channel blockers on pentylenetetrazol drug discrimination in rats.

Gatch MB, Wallis CJ, Lal H.

Alcohol. 2001 Apr;23(3):141-7.

PMID:
11435024
45.

Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.

Jung ME, Wallis CJ, Gatch MB, Lal H.

Alcohol. 2000 Jun;21(2):161-8.

PMID:
10963939
46.

Effects of ritanserin on ethanol withdrawal-induced anxiety in rats.

Gatch MB, Wallis CJ, Lal H.

Alcohol. 2000 May;21(1):11-7.

PMID:
10946153
47.

Sex differences in nicotine substitution to a pentylenetetrazol discriminative stimulus during ethanol withdrawal in rats.

Jung ME, Wallis CJ, Gatch MB, Lal H.

Psychopharmacology (Berl). 2000 Apr;149(3):235-40.

PMID:
10823403
48.

Sex differences in the discriminative stimulus effects of m-chlorophenylpiperazine and ethanol withdrawal.

Jung ME, Wallis CJ, Gatch MB, Lal H.

Psychopharmacology (Berl). 2000 Apr;149(2):170-5.

PMID:
10805612
49.

Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats.

Gatch MB.

Alcohol Clin Exp Res. 1999 Nov;23(11):1736-43.

PMID:
10591589
50.

Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze.

Gatch MB, Wallis CJ, Lal H.

Alcohol. 1999 Nov;19(3):207-11.

PMID:
10580509

Supplemental Content

Loading ...
Support Center